Skip to main content
Midas Edge

Investar Holding Corp

For the period ended Dec 31, 2023. Filed Mar 7, 2024.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Mar 7, 2024

ISTR$28.22+1.5%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Item 16. Form 10-K Summary

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

INVESTAR HOLDING CORPORATION
Date:March 7, 2024by:/s/ John J. D’Angelo
John J. D’Angelo
President and
Chief Executive Officer

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the date indicated.

Date:March 7, 2024by:/s/ John J. D’Angelo
John J. D’Angelo
President, Chief Executive
Officer and Director
(Principal Executive Officer)
Date:March 7, 2024by:/s/ John R. Campbell
John R. Campbell
Executive Vice President and
Chief Financial Officer
(Principal Financial Officer)
Date:March 7, 2024by:/s/ Corey E. Moore
Corey E. Moore
Senior Vice President and
Chief Accounting Officer
(Principal Accounting Officer)
Date:March 7, 2024by:/s/ Anita M. Fontenot
Anita M. Fontenot
Director
Date:March 7, 2024by:/s/ William H. Hidalgo, Sr.
William H. Hidalgo, Sr.
Chairman of the Board
Date:March 7, 2024by:/s/ Rose J. Hudson
Rose J. Hudson
Director
Date:March 7, 2024by:/s/ Gordon H. Joffrion, III
Gordon H. Joffrion, III
Director
Date:March 7, 2024by:/s/ Robert C. Jordan
Robert C. Jordan
Director
Date:March 7, 2024by:/s/ Julio A. Melara
Julio A. Melara
Director
Date:March 7, 2024by:/s/ Suzanne O. Middleton
Suzanne O. Middleton
Director
Date:March 7, 2024by:/s/ Andrew C. Nelson, M.D.
Andrew C. Nelson, M.D.
Director
Date:March 7, 2024by:/s/ Frank L. Walker
Frank L. Walker
Director
Date:March 7, 2024by:/s/ James E. Yegge, M.D.
James E. Yegge, M.D.
Director
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.